Histidine-Decarboxylase Knockout Mice Show Deficient Nonreinforced Episodic Object Memory, Improved Negatively Reinforced Water-Maze Performance, and Increased Neo- and Ventro-Striatal Dopamine Turnover

Learning and Memory

Volumn 10, Issue 6, 2003, Pages 510-519

  Dere, Ekrem ^a   De Souza Silva, Maria A ^a   Topic, Bianca ^a   Spieler, Richard E ^b   Haas, Helmut L ^a   Huston, Joseph P ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 O METHYLDOPAMINE; DIHYDROPHENYLACETIC ACID DERIVATIVE; DOPAMINE; HISTAMINE; HISTIDINE DECARBOXYLASE; PHENYLACETIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; EPISODIC OBJECT MEMORY; GENE DISRUPTION; KNOCKOUT MOUSE; LEARNING; MAZE TEST; MEMORY; MORRIS WATER MAZE TEST; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; SPATIAL MEMORY; TASK PERFORMANCE;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CORPUS STRIATUM; DOPAMINE; HISTAMINE; HISTIDINE DECARBOXYLASE; MALE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; MICE; MICE, KNOCKOUT; WATER;

EID: 0344197972     PISSN: 10720502     EISSN: None     Source Type: Journal    
DOI: 10.1101/lm.67603     Document Type: Article

References (65)

1. Airaksinen, M.S., Alanen, S., Szabat, E., Visser, T.J., and Panula, P. 1992. Multiple neurotransmitters in the tuberomammillary nucleus: Comparison of rat, mouse, and guinea pig. J. Comp. Neurol. 323: 103-116.
2. Alvarez, E.O. and Banzan, A.M. 1996. Hippocampus and learning: Possible role of histamine receptors. Medicina 56: 155-160.
3. Bannerman, D.M., Good, M.A., Butcher, S.P., Ramsay, M., and Morris, R.G. 1995. Distinct components of spatial learning revealed by prior training and NMDA receptor blockade. Nature 378: 182-186.
4. Bekkers, J.M. 1993. Enhancement by histamine of NMDA-mediated synaptic transmission in the hippocampus. Science 261: 104-106.
5. 3 receptor activation in rats. Br. J. Pharmacol. 119: 1656-1664.
6. Brown, R.E. and Haas, H.L. 1999. On the mechanism of histaminergic inhibition of glutamate release in the rat dentate gyrus. J. Physiol. 515: 777-786.
7. Brown, R.E., Fedorov, N.B., Haas, H.L., and Reymann, K.G. 1995. Histaminergic modulation of synaptic plasticity in area CA1 of rat hippocampal slices. Neuropharmacology 34: 181-190.
8. Brown, R.E., Stevens, D.R., and Haas, H.L. 2001. The physiology of brain histamine. Prog. Neurobiol. 63: 637-672.
9. Cavus, I. and Teyler, T.J. 1998. NMDA receptor-independent LTP in basal versus apical dendrites of CA1 pyramidal cells in rat hippocampal slice. Hippocampus 8: 373-379.
10. Chen, Z., Sugimoto, Y., and Kamei, C. 1999. Effects of intracerebroventricular injection of α-fluoromethylhistidine on radial maze performance in rats. Pharmacol. Biochem. Behav. 64: 513-518.
11. De Souza-Silva, M.A., Mattern, C., Häcker, R., Nogueira, P.J., Huston, J.P., and Schwarting, R.K. 1997. Intranasal administration of the dopaminergic agonists L-DOPA, amphetamine, and cocaine increases dopamine activity in the neostriatum: A microdialysis study in the rat. J. Neurochem. 68: 233-239.
12. Di Chiara, G., Acquas, E., and Carboni, E. 1991. Role of mesolimbic dopamine in the motivational effects of drugs: Brain dialysis and place preference studies. In The mesolimbic dopamine system: From motivation to action (eds. P. Willner and J. Scheel-Krüger), pp. 367-384. Wiley, Chichester, UK.
13. 1 receptor blockade. Naunyn Schmiedebergs Arch. Pharmacol. 358: 423-429.
14. Fibinger, H.C. and Phillips, A.G. 1988. Mesocorticolimbic dopamine systems and reward. In The mesocorticolimbic dopamine system (ed. P.W. Kalivas), Vol. 537, pp. 206-215. New York Academy of Sciences, NY.
15. 3 receptor modulation in the septum on post-training memory processing. Psychopharmacology 140: 279-284.
16. Frisch, C., Hasenöhrl, R.U., Haas, H.L., Weiler, H.T., Steinbusch, H.W.M., and Huston, J.P. 1998. Facilitation of learning after lesions of the tuberomammillary nucleus region in adult and aged rats. Exp. Brain Res. 118: 447-456.
17. Frisch, C., Hasenöhrl, R.U., and Huston, J.P. 1999. Memory improvement by post-trial injection of lidocaine into the tuberomammillary nucleus, the source of neuronal histamine. Neurobiol. Learn. Mem. 72: 69-77.
18. 1-receptor blockade. Neuropharmacology 40: 624-633.
19. Gerlai, R. 1999. Ethological approaches in behavioral neurogenetic research. In Handbook of molecular-genetic techniques for brain and behavior research; techniques in the behavioral and neural science (eds. W.E. Crusio and R.T. Gerlai), Vol. 13, pp. 605-613. Elsevier Science B.V., New York.
20. Grover, L.M. and Yan, C. 1999. Evidence for involvement of group II/III metabotropic glutamate receptors in NMDA receptor-independent long-term potentiation in area CA1 of rat hippocampus. J. Neurophysiol. 82: 2956-2969.
21. Haas, H. and Panula, P. 2003. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat. Rev. Neurosci. 4: 121-130.
22. 1 receptor antagonist chlorpheniramine improves maze performance and has anxiolytic-like effects in aged hybrid Fischer 344xBrown Norway rats. Exp. Brain Res. 128: 435-440.
23. Hill, S.J., Ganellin, C.R., Timmerman, H., Schwarz, J.C., Shankley, N.P., Young, J.M., Schunack, W., Levi, R., and Haas, H.L. 1997. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol. Rev. 49: 253-278.
24. Hoh, T., Beiko, J., Boon, F., Weiss, S., and Cain, D.P. 1999. Complex behavioral strategy and reversal learning in the water maze without NMDA receptor-dependent long-term potentiation. J. Neurosci. 19: RC2.
25. Huston, J.P. and Oitzl, M.S. 1989. The relationship between reinforcement and memory: Parallels in the rewarding and mnemonic effects of the neuropeptide substance P. Neurosci. Biobehav. Rev. 13: 171-180.
26. Huston, J.P., Wagner, U., and Hasenöhrl, R.U. 1997. The tuberomammillary nucleus in the control of learning, memory and reinforcement processes: Evidence for an inhibitory role. Behav. Brain Res. 83: 97-105.
27. Irifune, M., Nomoto, M., and Fukuda, T. 1995. Effects of GBR 12909 on locomotor activity and dopamine turnover in mice: Comparison with apomorphine. Eur. J. Pharmacol. 272: 79-85.
28. Kamei, C., Okumura, Y., and Tasaka, K. 1993. Influence of histamine depletion on learning and memory recollection in rats. Psychopharmacology 111: 376-382.
29. Köhler, C., Swanson, L.W., Haglund, L., and Wu, J.Y. 1985. The cytoarchitecture, histochemistry and projections of the tuberomammillary nucleus in the rat. Neuroscience 16: 85-110.
30. Kubota, Y., Ito, C., Sakurai, E., Sakurai, E., Watanabe, T., and Ohtsu, H. 2002. Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice. J. Neurochem. 83: 837-845.
31. Lin, J.S. 2000. Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons. Sleep Med. Rev. 4: 471-503.
32. Maisonnette, S., Huston, J.P., Brandao, M., and Schwarting, R.K. 1998. Behavioral asymmetries and neurochemical changes after unilateral lesions of tuberomammillary nucleus or substantia nigra. Exp. Brain Res. 120: 273-282.
33. Martin, S.J. and Morris, R.G. 2002. New life in an old idea: The synaptic plasticity and memory hypothesis revisited. Hippocampus 12: 609-636.
34. Masukawa, Y., Suzuki, T., and Misawa, M. 1993. Differential modification of the rewarding effects of methamphetamine and cocaine by opioids and antihistamines. Psychopharmacology 111: 139-143.
35. Ohtsu, H., Tanaka, S., Terui, T., Hori, Y., Makabe-Kobayashi, Y., Pejler, G., Tchougounova, E., Hellman, L., Gertsenstein, M., Hirasawa, N., et al. 2001. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett. 502: 53-56.
36. Onodera, K., Yamatodani, A., and Watanabe, T. 1992. Effects of α-fluoromethylhistidine on locomotor activity, brain histamine and catecholamine contents in rats. Exp. Clin. Pharmacol. 14: 97-105.
37. Onodera, K., Yamatodani, A., Watanabe, T., and Wada, H. 1994. Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders. Prog. Neurobiol. 42: 685-702.
38. Otnaess, M.K., Brun, V.H., Moser, M.B., and Moser, E.I. 1999. Pretraining prevents spatial learning impairment after saturation of hippocampal long-term potentiation. J. Neurosci. 19: RC49.
39. Parmentier, R., Ohtsu, H., Djebbara-Hannas, Z., Valatx, J.L., Watanabe, T., and Lin, J.S. 2002. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: Evidence for the role of brain histamine in behavioral and sleep-wake control. J. Neurosci. 22: 7695-7711.
40. 1 receptor-mediated facilitation of NMDA responses. Br. J. Pharmacol. 121: 199-204.
41. 3-receptor agonist, on the Morris water-maze in rat. Behav. Brain Res. 129: 77-82.
42. Sakai, N., Sakurai, E., Sakurai, E., Yanai, K., Mirua, Y., and Watanabe, T. 1998. Depletion of brain histamine induced by α-fluoromethyl-histidine enhances radial maze performance in rats with modulation of brain amino acid levels. Life Sci. 62: 989-994.
43. Schlicker, E., Fink, K., Detzner, M., and Gothert, M. 1993. Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors. J. Neural. Transm. Gen. Sect. 93: 1-10.
44. Schwarz, J.C., Arrang, J.M., Garbarg, M., Pollard, H., and Ruat, M. 1991. Histaminergic transmission in the mamalian brain. Physiol. Rev. 71: 1-51.
45. Selbach, O., Brown, R.E., and Haas, H.L. 1997. Long-term increase of hippocampal excitability by histamine and cyclic AMP. Neuropharmacology 36: 1539-1548.
46. Sethy, V.M. and Francis, J.W. 1988. Regulation of brain acetylcholine concentration by muscarinic receptors. J. Pharmacol. Exp. Ther. 246: 243-248.
47. Shannon, H.E. and Su, T.P. 1982. Effects of the combination of tripelennamine and pentazocine at the behavioral and molecular levels. Pharmacol. Biochem. Behav. 17: 789-795.
48. Steele, R.J. and Morris, R.G.M. 1999. Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5. Hippocampus 9: 118-136.
49. 1 receptor antagonist-induced spatial memory deficits in rats. Eur. J. Pharmacol. 423: 167-170.
50. Tang, Y.P., Shimiizu, E., Dube, G.R., Rampon, C., Kerchner, G.A., Zhuo, M., Liu, G., and Tsien, J.Z. 1999. Genetic enhancement of learning and memory in mice. Nature 401: 63-69.
51. Thomas, K.L., Davis, S., Hunt, S.P., and Laroche, S. 1996. Alterations in the expression of specific glutamate receptor subunits following hippocampal LTP in vivo. Learn. Mem. 3: 197-208.
52. Tsien, J.Z. 1998. Behavioral genetics: Subregion- and cell type-restricted gene knockout in mouse brain. Pathol. Biol. 46: 699-700.
53. Unterwald, E.M., Kucharski, L.T., Williams, J.E., and Kornetsky, C. 1984. Tripelennamine: Enhancement of brain-stimulation reward. Life Sci. 34: 149-153.
54. Vorobjev, V.S., Sharonova, I.N., Walsh, I.B., and Haas, H.L. 1993. Histamine potentiates N-methyl-D-aspartate responses in acutely isolated hippocampal neurons. Neuron 11: 837-844.
55. Wada, H., Inagaki, N., Yamatodani, A., and Watanabe, T. 1991. Is the histaminergic neuron system a regulatory center for whole-brain activity? Tends Neurosci. 14: 415-418.
56. Wagner, U., Weiler, H.T., and Huston, J.P. 1993. Amplification of rewarding hypothalamic stimulation following a unilateral lesion in the region of the tuberomammillary nucleus. Neuroscience 52: 927-932.
57. Watanabe, T., Yamatodani, A., Maeyama, K., and Wada, H. 1990. Pharmacology of α-fluoromethylhistidine, a specific inhibitor of histidine decarboxylase. Trends Pharmac. Sci. 11: 363-367.
58. Williams, J.M., Mason-Parker, S.E., Abraham, W.C., and Tate, W.P. 1998. Biphasic changes in the levels of N-methyl-D-aspartate receptor-2 subunits correlate with the induction and persistence of long-term potentiation. Mol. Brain Res. 60: 21-27.
59. Williams, K. 1994. Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine. Mol. Pharmacol. 46: 531-541.
60. Wise, R.A. 1996. Addictive drugs and brain stimulation reward. Annu. Rev. Neurosci. 19: 319-340.
61. Wood, P.L. and Altar, C.A. 1988. Dopamine release in vivo from nigrostriatal, mesolimbic, and mesocortical neurons: Utility of 3-methoxytyramine measurements. Pharmacol. Rev. 40: 163-187.
62. Yamatodani, A., Inagaki, N., Panula, P., Itowi, N., Watanabe, T., and Wada, H. 1991. Structure and functions of the histaminergic neurone system. In Histamine and histamine antagonists (ed. B. Uvnäs), pp. 243-283. Springer-Verlag, Berlin.
63. 1 receptors in mice: Behavioral and neurochemical characterization. Life Sci. 62: 1607-1610.
64. 1 receptors. Neuroscience 87: 479-487.
65. 1-histaminergic receptor blocker as measured with place-preference and self-stimulation behavior. Neuroscience 94: 93-103.